Related Experiment Videos
[The basic patterns in the development of lymph circulatory failure in the heart]
Summary
This study investigated heart lymphatic channel (LC) changes in rabbits under various conditions, including atherosclerosis. Findings reveal stereotyped adaptive and pathological changes in the heart
Area of Science:
- Cardiovascular Research
- Lymphatic System Biology
- Pathology and Pathophysiology
Background:
- The lymphatic channel (LC) plays a crucial role in cardiovascular health.
- Understanding adaptive and pathological changes in the heart's LC is vital for cardiovascular disease research.
- Previous studies have not fully elucidated the dynamic changes in cardiac LC under various physiological and pathological stressors.
Purpose of the Study:
- To investigate adaptive and pathological alterations in the heart's lymphatic channel (LC) in rabbits.
- To examine the reversibility of LC changes in alimentary atherosclerosis following dietary cholesterol withdrawal.
- To characterize the morphofunctional reactions and phased development of chronic lymph flow insufficiency in the heart.
Main Methods:
- Utilized 63 adult rabbits subjected to physical exercise, acute/relapsing coronary insufficiency, and alimentary atherosclerosis.
- Employed colored mass injections for LC visualization.
- Investigated LC using stereoangioscopy, clarified preparations, semithin sections, and electron microscopy.
Main Results:
- Observed stereotyped changes across different elements of the cardiac lymphatic network.
- Identified distinct, successively following phases in morphofunctional reactions leading to chronic heart lymph flow insufficiency.
- Demonstrated that cardiac LC changes in atherosclerosis can be reversible upon cholesterol exclusion from the diet.
Conclusions:
- Cardiac lymphatic channel alterations exhibit a stereotyped pattern in response to various stressors.
- The development of chronic heart lymph flow insufficiency progresses through distinct, sequential phases.
- Dietary interventions can potentially reverse pathological changes in the cardiac lymphatic system associated with atherosclerosis.